Hotline: new coronary devices (DES, BRS, DCB)
Coronary Interventions
Stents, scaffolds and DCB
Hotline / Late-Breaking Trials
Theatre Havane
Anchorperson: Robert Byrne
Spokesperson: Ran Kornowski
Discussants: Mohammad Al Otaiby, Mirvat Alasnag, Michael Haude, Upendra Kaul
A randomised trial of iron bioresorbable scaffold compared with XIENCE in coronary artery disease
Lei Song
Discussion and audience interaction
Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes
Alexandre Abizaid
Discussion and audience interaction
Two-year clinical outcomes of the BIOADAPTOR RCT study
Shigeru Saito
Discussion and audience interaction
Results of the magnesium BRS in complex lesions: data from the IT-Masters registry
Stefano Galli
Discussion and audience interaction
Randomised trial of biolimus vs paclitaxel coated balloons for coronary in-stent restenosis
Lei Gao
Discussion and audience interaction
Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study
Bernardo Cortese
Discussion and audience interaction
Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study
Roxana Mehran
Discussion and audience interaction
Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures
Simon Eccleshall
Discussion and audience interaction
